Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
Narayanasamy S, Curtis LH, Hernandez AF, Woods CW, Moody MA, Sulkowski M, Turbett SE, Baden LR, Gulick RM, Pau AK, Adam SJ, Marks P, Stockbridge NL, Dobbins JR, Krofah E, Leav B, Pang P, Roessig L, Vedin O, Waldstreicher J, Berman SC, Cremisi H, Schofield L, Gandhi RT, Naggie S. Narayanasamy S, et al. Among authors: vedin o. Clin Infect Dis. 2023 Dec 15;77(12):1635-1643. doi: 10.1093/cid/ciad418. Clin Infect Dis. 2023. PMID: 37435958 Free PMC article.
"Click and mortar" opportunities for digitization and consumerism in trials.
Randell RL, Hornik CP, Curtis L, Hernandez AF, Denwood T, Nebeker C, Sugarman J, Tyl B, Murakami M, Oley Wilberforce L, Pagoto S, Vedin O, Andersson T, Carrasquillo O, Dolor R, Kollins SH, Pellegrino J, Ranney ML. Randell RL, et al. Among authors: vedin o. Contemp Clin Trials. 2023 Sep;132:107304. doi: 10.1016/j.cct.2023.107304. Epub 2023 Jul 20. Contemp Clin Trials. 2023. PMID: 37481202 Free PMC article.
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
Khan MS, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Chopra VK, Piña IL, Böhm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Peil B, Zannad F, Packer M, Butler J. Khan MS, et al. Among authors: vedin o. J Card Fail. 2023 Oct;29(10):1345-1354. doi: 10.1016/j.cardfail.2023.06.024. Epub 2023 Aug 8. J Card Fail. 2023. PMID: 37558088 Free article.
Health status across major subgroups of patients with heart failure and preserved ejection fraction.
Siddiqi TJ, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Böhm M, Brueckmann M, Chopra VK, Iwata T, Januzzi J, Piña IL, Ponikowski P, Senni M, Vedin O, Verma S, Zhang Y, Zannad F, Packer M, Butler J. Siddiqi TJ, et al. Among authors: vedin o. Eur J Heart Fail. 2023 Sep;25(9):1623-1631. doi: 10.1002/ejhf.2831. Epub 2023 Apr 4. Eur J Heart Fail. 2023. PMID: 36974746
Diabetes registries and high-quality diabetes care.
Khunti K, Mathieu C, Torbeyns B, Del Prato S, Heine R; EUDF Strategic Forum Data and Registries. Khunti K, et al. Lancet Diabetes Endocrinol. 2023 Feb;11(2):70-72. doi: 10.1016/S2213-8587(22)00386-2. Lancet Diabetes Endocrinol. 2023. PMID: 36702562 No abstract available.
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause.
Khan MS, Butler J, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Piña IL, Böhm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Zeller C, Zannad F, Packer M. Khan MS, et al. Among authors: vedin o. J Am Heart Assoc. 2023 Jan 3;12(1):e027652. doi: 10.1161/JAHA.122.027652. Epub 2022 Dec 24. J Am Heart Assoc. 2023. PMID: 36565199 Free PMC article. Clinical Trial.
Patients With Bicuspid Aortic Stenosis Demonstrate Adverse Left Ventricular Remodeling and Impaired Cardiac Function Before Surgery With Increased Risk of Postoperative Heart Failure.
Wedin JO, Vedin O, Rodin S, Simonson OE, Hörsne Malmborg J, Pallin J, James SK, Flachskampf FA, Ståhle E, Grinnemo KH. Wedin JO, et al. Among authors: vedin o. Circulation. 2022 Oct 25;146(17):1310-1322. doi: 10.1161/CIRCULATIONAHA.122.060125. Epub 2022 Aug 16. Circulation. 2022. PMID: 35971843 Free PMC article.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
Januzzi JL Jr, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Sattar N, Verma S, Vedin O, Iwata T, Brueckmann M, Packer M, Anker SD; EMPEROR-Preserved Trial Study Group. Januzzi JL Jr, et al. Among authors: vedin o. JACC Heart Fail. 2022 Jul;10(7):512-524. doi: 10.1016/j.jchf.2022.05.004. Epub 2022 Jun 1. JACC Heart Fail. 2022. PMID: 35670067 Free article.
45 results